NCT06480383 - Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder | Biotech Hunter

Enrollment

705

Participants

Timeline

Start Date

August 5, 2024

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions

Generalized Anxiety Disorder

Interventions

DRUG

ITI-1284 10 mg

ITI-1284 10 mg tablet, taken once daily, sublingual administration.

DRUG

ITI-1284 20 mg

ITI-1284 20 mg tablet, taken once daily, sublingual administration.

DRUG

Placebo

Matching placebo tablet, taken once daily, sublingual administration

Trial Locations (30)

11235

RECRUITING

Clinical Site, Brooklyn

18104

RECRUITING

Clinical Site, Allentown

19063

RECRUITING

Clinical Site, Media

30030

RECRUITING

Clinical Site, Decatur

30331

RECRUITING

Clinical Site, Atlanta

32607

WITHDRAWN

Clinical Site, Gainesville

32751

RECRUITING

Clinical Site, Maitland

32803

RECRUITING

Clinical Site, Orlando

33125

RECRUITING

Clinical Site, Miami

33166

RECRUITING

Clinical Site, Miami Springs

33176

RECRUITING

Clinical Site, Miami

33319

RECRUITING

Clinical Site, Lauderhill

33607

RECRUITING

Clinical Site, Tampa

44720

RECRUITING

Clinical Site, North Canton

73120

RECRUITING

Clinical Site, Oklahoma City

75093

RECRUITING

Clinical Site, Plano

75115

RECRUITING

Clinical SIte, DeSoto

78737

RECRUITING

Clinical Site, Austin

78759

RECRUITING

Clinical Site, Austin

85102

NOT_YET_RECRUITING

Clinical Site, Phoenix

85224

RECRUITING

Clinical Site, Chandler

91206

RECRUITING

Clinical Site, Glendale

91316

RECRUITING

Clinical Site, Encino

91945

RECRUITING

Clinical Site, Lemon Grove

92056

RECRUITING

Clinical Site, Oceanside

92108

NOT_YET_RECRUITING

Clinical Site, San Diego

92374

RECRUITING

Clinical Site, Redlands

92868

RECRUITING

Clinical Site, Orange

98007

RECRUITING

Clinical Site, Bellevue

02131

RECRUITING

Clinical Site, Boston